Atossa Therapeutics (ATOS) announced the appointment of Michael Parks as Vice President, VP, of Investor and Public Relations. Parks brings nearly 30 years of investor relations and corporate communications experience working globally within the biopharmaceutical and healthcare industries. Prior to joining Atossa, Parks was Vice President of Investor Relations at PAVmed (PAVM)
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATOS:
- Atossa Therapeutics Announces the Appointment of Michael Parks as Vice President, Investor and Public Relations
- Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
- Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz
- Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
- Atossa Therapeutics reports Q2 EPS (5c), consensus (6c)
Questions or Comments about the article? Write to editor@tipranks.com